Oragenics Enters Into Material Transfer Agreement With Adjuvance Technologies for COVID-19 Vaccine Adjuvant January 7, 2021
FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine October 6, 2020
Oragenics Inc. to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference September 11, 2020
